首页> 美国卫生研究院文献>Critical Care >Clinical review: Does it matter which hemodynamic monitoring system is used?
【2h】

Clinical review: Does it matter which hemodynamic monitoring system is used?

机译:临床评论:使用哪种血液动力学监测系统是否重要?

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hemodynamic monitoring and management has greatly improved during the past decade. Technologies have evolved from very invasive to non-invasive, and the philosophy has shifted from a static approach to a functional approach. However, despite these major changes, the critical care community still has potential to improve its ability to adopt the most modern standards of research methodology in order to more effectively evaluate new monitoring systems and their impact on patient outcome. Today, despite the huge enthusiasm raised by new hemodynamic monitoring systems, there is still a big gap between clinical research studies evaluating these monitors and clinical practice. A few studies, especially in the perioperative period, have shown that hemodynamic monitoring systems coupled with treatment protocols can improve patient outcome. These trials are small and, overall, the corpus of science related to this topic does not yet fit the standard of clinical research methodology encountered in other specialties such as cardiology and oncology. Larger randomized trials or quality improvement processes will probably answer questions related to the real impact of these systems.
机译:在过去十年中,血流动力学监测和管理已大大改善。技术已经从高度侵入性发展到非侵入性,并且其哲学已经从静态方法转变为功能性方法。然而,尽管发生了这些重大变化,重症监护社区仍然有潜力提高其采用最现代研究方法标准的能力,以便更有效地评估新的监测系统及其对患者结果的影响。如今,尽管新型血液动力学监测系统引起了人们的极大热情,但评估这些监测器的临床研究与临床实践之间仍然存在很大差距。一些研究,尤其是围手术期的研究表明,血液动力学监测系统与治疗方案相结合可以改善患者的预后。这些试验规模很小,并且总体而言,与该主题相关的科学文献尚不能满足心脏病学和肿瘤学等其他专业所遇到的临床研究方法论的标准。较大的随机试验或质量改进过程可能会回答与这些系统的实际影响有关的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号